IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 205 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $370,000 | -31.9% | 11,700 | 0.0% | 0.01% | -44.0% |
| Q4 2020 | $543,000 | -6.9% | 11,700 | -33.9% | 0.02% | -16.7% |
| Q3 2020 | $583,000 | +15.4% | 17,700 | -3.8% | 0.03% | +7.1% |
| Q2 2020 | $505,000 | -74.7% | 18,400 | -72.4% | 0.03% | -80.3% |
| Q1 2020 | $1,994,000 | -58.4% | 66,600 | -77.0% | 0.14% | -47.4% |
| Q4 2019 | $4,792,000 | +52.7% | 289,500 | +67.9% | 0.27% | +42.1% |
| Q3 2019 | $3,138,000 | – | 172,400 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
| Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
| Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
| Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
| Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
| Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
| QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
| Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |